Central Nervous System Prescription Drug Use and Payments in Medicaid

REFERENCES

• US Department of Health and Human Services. Centers for Medicare & Medicaid Services. Medicaid at-a-glance: 2002, a Medicaid information source. No date; publication no. CMS–11024–02.
   Google Scholar
• US Department of Health and Human Services. Centers for Medicare & Medicaid Services. www.cms.gov/states/maaghm.asp (accessed 3 Sept 2004).
   Google Scholar
• Bruen B. States strive to limit Medicaid expenditures for prescribed drugs. Washington, DC: Kaiser Commission on Medicaid and the Uninsured, Feb 2002; Kai-ser Family Foundation No. 4030.
   Google Scholar
• Levit K, Smith C, Cowan C, Lazenby H, Sensenig A, Catlin A. Trends in U.S. health care spending, 2001. Health Aff 2003; 22(Jan/Feb):154–64.
   Google Scholar
• Briesacher B, Stuart B, Doshi J, Kamal-Bahl S, Shea D. Medicare's disabled ben-eficiaries: The forgotten population in the debate over drug benefits. New York and Washington, DC: The Commonwealth Fund and the Henry J. Kaiser Family Foundation, Sept 2002; Commonwealth Fund No. 573 and Kaiser Family Foundation No. 6054.
   Google Scholar
• Smith V, Ellis E. Medicaid budgets under stress: Survey findings for states fis-cal years 2000,2001 and 2002. Washington, DC: Kaiser Commission on Medicaid and the Uninsured, Oct 2001; Kaiser Family Foundation No. 4020.
   Google Scholar
• Kaiser Commission on Medicaid and the Uninsured. State budgets under stress: How are states planning to reduce the growth in Medicaid costs? Washington, DC: Kaiser Commission on Medicaid and the Uninsured, 30 Jul 2002.
   Google Scholar
• Toner R, Pear R. Cutbacks imperil health coverage for states' poor. New York Times. 28 Apr 2003.
   Google Scholar
• Desonia R. Running on empty: The state budget crisis worsens. National Health Pol-icy Forum Issue Brief No. 783. Washington, DC: George Washington University, 25 Sept 2002.
   Google Scholar
• Holahan J, Weiner JM, Lutzky AW. Health policy for low-income people: States' responses to new challenges. Health Aff Web exclusive, 22 May 2002. con-tent.healthaffairs. org/cgi/content/full/hlthaff. w2.187v1/DC1 (accessed 2004 Sept 14).
   Google Scholar
• IIVIS Health. Global pharma sales up 10% in December 1999. secure.imshealth. com/public/structure/dispcontent/1,2779,2018-2108-22429,00.htm (accessed 2004 Sept 3).
   Google Scholar
• IIVIS Health. Top therapy areas. www.imsglobal.com/insight/world_in_brief/ 0006/therapy.htm (access 2004 Sept 3).
   Google Scholar
• Gadsby JE. Antidepressants, a global perspective! Prescribing, diagnoses and drug marketing trends. Presentation at Symposium on Neuropsychiatric Adverse Ef-fects of SSRI Medications Psychosis, Seizures and Suicide. Philadelphia, PA; 2002 Oct 4–5.
   Google Scholar
• Croghan T. The controversy of increased spending for antidepressants. Health Aff 2001; 20(Mar/Apr):129–35.
   Google Scholar
• Frank RG, Goldman HH, Hogan M. Medicaid and mental health: Be careful what you ask for. Health Aff 2003; 22(Jan/Feb):101–13.
   Google Scholar
• Mark TL, Coffey RM. Trends: What drove private health insurance spending on mental health and substance abuse care, 1992-1999? Health Aff 2003; 22(Jan/Feb): 165–72.
   Google Scholar
• Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade S. Explaining drug spending trends: Does perception match reality? Health Aff 2000; 19(Mar/Apr):231–9.
   Google Scholar
• Merlis M. Explaining the growth in prescription drug spending: A review of re-cent studies. Report prepared for the Department of Health and Human Services, Con-ference on Pharmaceutical Pricing Practices, Utilization and Costs, August 2000. Available at www.aspe.hhs.gov/health/reports/Drug-papers/merlis/Merlis-Final.htm (ac-cessed 2004 Sept 14).
   Google Scholar
• University of Minnesota, Research Data Assistance Center (ResDAC). Brief de-scriptions of SMRF and MAX files. www.resdac.ummedu/Medicaid/file_descriptions. asp (accessed 2003 May 8).
   Google Scholar
• US Department of Health and Human Services. Centers for Medicare & Medicaid Services. Medicaid statistics and data. www.cms.gov/medicaid/mcaidsad. asp (accessed 2004 Sept 3).
   Google Scholar
• Wolters Kluwer Health. Master Drug Data Base. www.Medi-Span.com/products/ product_mddb.asp (2003 May 13).
   Google Scholar
• Swan JH. Unpublished data. State Medicaid Reimbursement Surveys, 1998–99 (updated 2002), Department of Health Sciences, Wichita State University.
   Google Scholar
• Drugtopics.com. An update on Medicaid reimbursement by state-2002. www.drugtopics.com/be_core/d/templates/issue/show_articlejsp?stylesheet =/be_core/ d/stylesheets/xslt/view_free_pages.xsl&filename=/be_core/d/onine_only_content/free_ pages/managecare.xml&showPoll = no (2004 accessed Feb 17).
   Google Scholar
• Pincus HA, Tanielian T, Marcus S, Olfson M, Zarin D, Thompson J, Zito TM. Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties. JAMA. 1998; 279:526–31.
   Google Scholar
• Zito TM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F. Trends in the pre-scribing of psychotropic medications to preschoolers. JAMA. 2000; 283:1025–30.
   PubMed Web of Science ®Google Scholar
• Zito TM, Safer DJ, dosReis S, et al. Psychotropic practice patterns for youth: A 10-year perspective. Arch Pediatr Adolesc Med. 2003; 157:17–25.
   PubMed Web of Science ®Google Scholar
• Baugh DK, Pine PL, Blackwell S. Trends in Medicaid prescription drug utiliza-tion and payments, 1990–97. Health Care Financ Rev. 1999; 20(3):79–105.
   Google Scholar
• Hollon MF. Direct-to-consumer marketing of prescription drugs: A current per-spective for neurologists and psychiatrists. CNS Drugs. 2004; 18(2):69–77.
   PubMed Web of Science ®Google Scholar
• Harwood HJ, Mark TL, McKusick DR, Coffey RM, King EC, Genuardi JS. Na-tional spending on mental health and substance abuse treatment by age of clients, 1997. J Behav Health Serv Res. 2003; 30:433–43.
   PubMedGoogle Scholar